Fluorescent In Situ Hybridisation (FISH) testing for ALK or ROS in NSCLC
Targeted FISH probes for NSCLC tissue to determine access to tepotinib.
FISH Testing for NSCLC
Testing of non-small lung cancer tissue to determine eligibility for access to tepotinib under the PBS.
ALK (2p23), ROS1 (6q22.1)
FISH
1 week from receipt of slides
Please all 1800 822 999 if not Medicare eligible.
Standard pathology request form.
FFPE Tumour Tissue
FFPE
1 x H&E circled by a histopathologist (with the % tumour content indicated) plus 2-3 micron unstained sections on sticky (charged) slides.
For one probe: 6 slides
For multiple probes: 10 slides